 |
| NFRX is Setting Up Nicely. PSID Aligns with Another Strong Player |
|
 Yesterday's Top Performer |
Company: InferX Corp. (Pink Sheets: NFRX)
|
End of Day:
Price: 0.08
Change (%): + 0.015 (23.08)
Volume: 166,000 |
 |
InferX is the market leader in next generation distributed Predictive Analytics and Business Intelligence Products and Solutions. InferX has pioneered and commercialized a powerful, patented suite of advanced data analytical solutions that improve corporate performance across the enterprise in the healthcare, financial services, and government markets. InferX is uniquely capable of delivering secure, real-time, and privacy preserving intelligence and decision support - all without the need to move data. InferX is headquartered in Sterling, VA.
Company Information Sheet
|
 Hot Stock to Watch
|
Company: PositiveID Corporation (OTCBB: PSID)
|
End of Day:
Price: 0.0235
Change (%): - 0.0005 (2.08)
Volume: 4,138,472 |
 |
PositiveID Corporation Retains Secure Strategy Group
DELRAY BEACH, Fla. and NEW YORK, Jan. 8, 2013 (GLOBE NEWSWIRE) - PositiveID Corporation (“PositiveID”) (PSID), an emerging growth company and developer of airborne bio-threat detection systems for America´s homeland defense industry as well as advanced technologies for rapid medical testing and diabetes management, today announced it has retained Secure Strategy Group (“SSG”) for strategic and financial advisory services.
“As we at PositiveID continue to focus on our molecular diagnostic technologies, specifically our M-BAND airborne bio-threat detector and Dragonfly(TM) Rapid MD-x Cartridge-based diagnostic system, we are pleased to work closely with SSG, which has a strong track record assisting companies that address critical needs for homeland security,” commented William J. Caragol, Chairman and CEO of PositiveID. “The team at SSG includes leaders experienced in securing federal government and commercial opportunities, and we believe that by working together, PositiveID will be able to increase value for our stockholders.”
Continue Reading |
Other Small Cap News
|
Company: Vista Gold Corp. (NYSE Amex: VGZ)
|
Vista Gold Corp. To Present At Dahlman Rose 4th Annual Precious Metals Conference
DENVER, Jan. 7, 2013 /PRNewswire/ -- Vista Gold Corp. (TSX & NYSE MKT: VGZ) ("Vista") is pleased to announce that Fred Earnest , President and CEO, will present at the Dahlman Rose 4th Annual Precious Metals Conference in New York on Wednesday, January 9, at 1:30 pm ET. Mr. Earnest will provide an update on Vista's world-class Mt. Todd gold project as well as a corporate overview.
Continue Reading
|
Company: Voice Assist, Inc. (OTCBB: VSST)
|
Voice Assist Handsfree Safe Driving Application now available on the Apple App Store
LAKE FOREST, Calif., Jan. 8, 2013 /PRNewswire/ -- Voice Assist, Inc. (OTCBB: VSST), an award-winning provider of mobile speech and handsfree solutions, announced today the availability of its Voice Assist App for iPhone.
Voice Assist for iPhone is a safe driving application that lets drivers use voice commands to call, email, text and post to social networks like Twitter and Facebook with no typing required.
Continue Reading
|
Company: Amarantus BioScience, Inc. (OTCQB: AMBS)
|
Amarantus Bioscience Neurorestoration Animal Data Presentation to be Webcast Live Today from OneMedForum 2013 at 4:40pm Eastern
SUNNYVALE, Calif., Jan. 8, 2013 /PRNewswire/ -- Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments for diseases associated with protein misfolding and apoptosis, today announced that Dr. John W. Commissiong , CSO will present results of its MANF Parkinson's disease neurorestoration animal studies at the OneMedForum SF 2013 conference on Tuesday, January 8, 2013 at 4:40pm ET. The presentation will be webcast live at the link: http://bit.ly/WtXDQp. Advisor Dr. Joseph Rubinfeld will follow Dr. Commissiong's data presentation, and briefly discuss MANF's potential in areas beyond Parkinson's disease.
Continue Reading |
Market News
|
By Matt Nesto: Breakout
|
Money in the Banks: How Financials Can Extend the Rally
It was kind of like that lost Christmas package that arrives a few days late, only in this case, the gift didn't arrive in the mail -- it came in the form of a press release from Basel, Switzerland.
The present was even bigger than expected, and the banks receiving it were overjoyed. Known as the "LCR" (liquidity coverage ratio), the revised capital requirements financial companies will have are not only easier, but the lenders subjected to them will get an extra four years in which to comply, out until 2019.
The news was the latest shot in the arm for the beleaguered banks, says Kenny Polcari, a NYSE-based floor trader and director at O'Neil Securities. "It's a group that we need to lead," he adds in the attached video, pointing out that revitalized banks carry broader benefits for the markets and the economy.
Continue Reading
|
By Marc Jones: Reuters
|
Global shares recover, euro steady as euro zone data stabilizes
(Reuters) - European shares edged up on Tuesday as data signaled the euro zone economy may be stabilizing at a weak level, and the euro held steady while commodity markets were largely subdued as investors sat on recent gains.
The data was mixed. Euro zone business confidence improved again in December, but unemployment reached a new record and households held back from spending in the run-up to Christmas, suggesting a recovery from recession will be slow. German industrial orders also fell more than forecast due to a sharp drop in demand from abroad.
Continue Reading |
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
